Discover Great Companies Discover Great Clients
Popularity  6.1万   |   Followers  35   |   Likes  25   |   Feedback  40 Claim this company

A listed enterprise primarily engaged in the R&D, production, and sale

No.35 Daxing District Popularity Ranking Beijing No.1 Culture Media No.1 Zhi Shi Chan Quan Guan Biao No.2 GMP Production No.3 Vaccines R&D No.4 He Suan Yao Products No.5 Lin Chuang Qian Yan Jiu No.8 Ren Yong Yi Miao No.9 Vaccines Technology No.10 Vaccines No.14 Healthcare Healthy No.21 Biotechnology Pharmaceuticals No.21 Sheng Ming Ke Xue 院士工作站 博士后工作站 高新技术企业 国家知识产权示范企业 企业技术中心 专利示范企业
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 22年
  • Industry: Pharmaceuticals/Bioengineering 、 Raw Materials and Processing 、 Beauty/Healthcare
  • Full name: Beijing Minhai Biotechnology Co., Ltd.。

Development Stage

  • Ranking: Ranked #1 in Beijing Culture Media Company by popularity Ranked #1 in Beijing Zhi Shi Chan Quan Guan Biao Company by popularity Ranked #2 in Beijing GMP Production Company by popularity Ranked #3 in Beijing Vaccines R&D Company by popularity
  • Honors: 院士工作站 博士后工作站 According to algorithm
  • Salary: 75.4% of positions earn 10-50K, In 2026 vs last yeargrew by 14%.。Master's salary: ¥28.7K, Doctorate salary: ¥25.0K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 24.6%, "Other (R&D and Technical)": 8.8%, "Computer/Network/Technology": 8.8%。
  • Recruiting: In 2026 vs 2025decreased by 13%. Demand for highly educated talent: Master's: 4.
  • Requirement: Education: 本科 leads with 65.3%. Experience: 不限 leads with 32.4%.
  • Region: Distributed across 3 regions, 北京: 80.3%, 深圳: 5.8%, 成都: 2.9%, 杭州: 1.2%.

About the Company

[Summary] A listed enterprise primarily engaged in the R&D, production, and sale

Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as Minhai Company) is located at No. 35 Simiao Road, Daxing Biomedical Industry Base, Zhongguancun Science Park, and was established in June 2004 with an investment scale of nearly 2 billion yuan. In 2008, it underwent strategic restructuring with Shenzhen Kangtai Biological Products Co., Ltd. (listed on February 7, 2017, stock code: 300601), becoming its wholly-owned subsidiary. Minhai Company has always been a national high-tech enterprise and a G20 enterprise in Beijing, with its main business being the R&D, production, and sales of human-use vaccine products.

Phase I of Minhai Company covers an area of 100 mu and began production in 2012. To date, four vaccine products have been launched on the market: "Acellular DTP-Hib Combined Vaccine," "Hib Conjugate Vaccine," "Measles and Rubella Combined Live Attenuated Vaccine," and "23-valent Pneumococcal Polysaccharide Vaccine," breaking the foreign technology monopoly. The company has established a sound market operation and management mechanism, with sales coverage across 31 provinces, municipalities, and autonomous regions nationwide, and sales revenue has grown by more than 50% annually over the past three years. Phase II covers 135 mu, and project initiation and environmental impact assessment were completed in April 2019.

Minhai Company currently employs 1,336 people, including 230 R&D personnel and 90 with master's degrees or above. Five team leaders have successively received the honorary title of "New Creation Project." Multiple core technical personnel have led or participated in over 40 national, provincial, and municipal science and technology projects, including 863 and Major New Drug Creation programs, with cumulative support funds exceeding 200 million yuan. It has also established a "Postdoctoral Research Workstation" and "Academician Expert Workstation," recruiting experts in the biomedical field to provide strong support for the strategic direction of vaccine R&D and tackling difficulties in the development process. It has over 20 ongoing R&D projects, with cumulative R&D investment of approximately 600 million yuan over the years. Additionally, four vaccine products have applied for production registration approvals and are under review; 11 vaccine products have obtained clinical trial approvals and are undergoing clinical trials; and several vaccine products are in preclinical research, indicating a rich and sustained product pipeline.

Through independent technological innovation, Minhai Company has established six modern new vaccine R&D technology platforms. To date, it has applied for 37 national invention patents and has been granted 21 invention patents, including one PCT patent. In December 2018, it passed the intellectual property management system certification and obtained the "Intellectual Property Management System Certification Certificate" issued by Zhongzhi (Beijing) Certification Co., Ltd. In addition, Minhai Company has numerous honorary qualifications: "Beijing Enterprise Technology Center," Beijing's "G20 Engineering Enterprise," "Beijing Key Laboratory of New Conjugate Vaccine Technology," "Beijing Engineering Laboratory for New Vaccines," "Beijing Engineering Technology Research Center for New Combined Vaccines," "Beijing International Science and Technology Cooperation Base for New Vaccines," "Beijing Patent Demonstration Unit," "National and Local Joint Engineering Laboratory for New Vaccine Technology Development," "Academician Expert Workstation," "Postdoctoral Research Workstation," "Liu Jiankai Innovation Studio," and "National Model Worker Pioneer," among others.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Minhai Biotech How Fast Is Hiring Growing? (42 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 85%
  • 2024: Down 37%
  • 2023: Up 2%
  • 2022: Down 35%
Minhai Biotech Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Minhai Biotech Campus Recruitment & Advanced Degree Talent Demand
Interns 1 Master's 4
Note: How fast is hiring at Beijing Minhai Biotechnology Co., Ltd. growing? Minhai Biotech2026: 139 openings (down 13%), 2025: 159 openings (up 85%), 2024: 86 openings (down 37%), 2023: 137 openings (up 2%), 2022: 134 openings (down 35%), 2021: 206 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Minhai Biotech Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 17%
  • 2024: Down 60%
  • 2023: Down 21%
  • 2022: Up 90%
Minhai Biotech Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Beijing Minhai Biotechnology Co., Ltd. growing? Minhai BiotechMaster's recruitment over the years: 2025: 5 openings (down 17%), 2024: 6 openings (down 60%), 2023: 15 openings (down 21%), 2022: 19 openings (up 90%), 2021: 10 openings.

Minhai Biotech Doctoral Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
Minhai Biotech Doctoral Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Beijing Minhai Biotechnology Co., Ltd. growing? Minhai BiotechDoctorate recruitment over the years: 2026: 2 openings (up 140%), 2025: 2 openings (down 17%), 2023: 3 openings (down 21%), 2022: 6 openings (up 90%), 2021: 1 openings.

Minhai Biotech R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Beijing Minhai Biotechnology Co., Ltd.? Based on an analysis of Minhai Biotech's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 24.6%, "Other (R&D and Technical)": 8.8%, "Computer/Network/Technology": 8.8%, "Medical & Health/Beauty & Healthcare": 4.7%, "Mechanical/Instrumentation": 2.3%, "Electrical/Energy/Power": 2.3%. For reference only.

Minhai Biotech — What Are the Salaries Like? (171 records)

Manage
Minhai Biotech Salary Overview
salary range: 6K - 50K, 75.4% of roles pay ¥10-50K
Note: salary statistics are based on 171 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Beijing Minhai Biotechnology Co., Ltd.?Minhai Biotech75.4% of positions earn 10-50K, Undergraduate salary: ¥。Beijing salary ranking: #2662,生物/制药/化工/环保类 average salary ¥17.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Minhai Biotech

(More)
Are salaries high at Beijing Minhai Biotechnology Co., Ltd.? We provide: Biopharmaceutical, Quality, Marketing, New Media Specialist, Sales, QC, Pharmaceutical Sales Representative, Brand, Vice President, Product Manager, HR Specialist, International Registration Specialist, Academic Manager, Finance Specialist, Intern, 注册专员, Administrative Specialist, Senior Supervisor, mes, Product Manager. Click to view detailed salary analysis by job.

Job Category

  • 生物/制药/化工/环保类
    24.3% of total 24.3%
  • 经营管理类
    23.7% of total 23.7%
  • 工厂生产类
    15.6% of total 15.6%
  • 质量管理类
    15.6% of total 15.6%

Education

  • 本科
    65.3% of total 65.3%
  • 大专
    21.4% of total 21.4%
  • 硕士
    7.5% of total 7.5%
  • 不限
    3.5% of total 3.5%

Experience

  • 不限
    32.4% of total 32.4%
  • 5-10年
    28.9% of total 28.9%
  • 3-5年
    23.1% of total 23.1%
  • 1-3年
    15.6% of total 15.6%
View Detailed Analysis

What does Beijing Minhai Biotechnology Co., Ltd. require? Who is Minhai Biotech hiring? Minhai Biotech recruitment: 生物/制药/化工/环保类占比最多占24.3%,其次是经营管理类占23.7%. What education can get in at Minhai Biotech? 本科占比最多占65.3%,其次是大专占21.4%. High education required at Minhai Biotech? 硕士占7.5%,博士占1.7%. Work experience required at Minhai Biotech? 不限占比最多占32.4%,其次是5-10年占28.9%. Where are the job locations at Minhai Biotech? 北京占比最多占80.3%,其次是深圳占5.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 100,000万(元)
Legal Representative: 杜伟民
Date Established:
Credit Code: 911100007635353107
Registered Address: 北京市大兴区中关村科技园区大兴生物医药产业基地思邈路35号、天富街25号

Partners & Suppliers

采购纳微科技的色谱填料用于疫苗等生物制品生产 Source
供应商 生物医药色谱填料
经销商,疫苗物流及分销服务 Source
合作客户 医药商业/经销商
经销商,区域性疫苗分销合作 Source
合作客户 医药商业/经销商
经销商,负责疫苗产品的全国配送与销售 Source
合作客户 医药商业/经销商
供应疫苗用预灌封注射器 Source
供应商 预灌封注射器/包装材料

People who follow Minhai Biotech also follow

Minhai Biotech Competitors (Similar Companies)

“Large-scale pharmaceutical distribution enterprise”
“Engaged in the research and development as well as technical services ”
疫苗 医药 生物制品 生物医药
“A pharmaceutical enterprise with over 70 years of glorious history”
“Although the processing is complicated, we dare not save labor; althou”
设计院 电力 电力设计院 电力设计
“A high-tech enterprise engaged in the research, development, and produ”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“Mainly engaged in comprehensive printing services for full-color publi”
“Large pharmaceutical group”
“High-end semiconductor quality control equipment”
“An international biopharmaceutical company driven by innovative techno”
生物制品 化学制药 医疗器械 生产
中成药 生产 制药/药业 中医药
“Pursuing health for all”

Discover Great Companies, Discover Great Clients

北京公司名录 北京“Daxing District”公司名录 北京“制药/药业”公司名录 北京“生物科技/生物工程”公司名录 北京“医药”公司名录 北京“疫苗”公司名录 北京“疫苗研发”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates